Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Journal of Internal Medicine|November 20, 2008
Inflammatory cells and immune microenvironment in malignant lymphomaD de Jong, G EnbladAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Treatment outcome in Hodgkin's disease in patients above the age of 60: a population-based studyG Enblad, B Glimelius, C SundströmActa Oncologica (Stockholm, Sweden)|January 1, 1996
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas: a Swedish national prospective study. Swedish Lymphoma Study GroupG Enblad, H Hagberg, B GlimeliusHistopathology|June 1, 1993
Immunohistochemical characteristics of Hodgkin and Reed-Sternberg cells in relation to age and clinical outcomeG Enblad, C Sundström, B GlimeliusHematological Oncology|July 1, 1993
Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosisG Enblad, C Sundstrom, B GlimeliusActa Oncologica (Stockholm, Sweden)|January 1, 1990
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study GroupG Enblad, B Glimelius, H Hagberg, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Serum levels of interleukin-2 receptor (CD 25) in patients with Hodgkin's disease, with special reference to age and prognosisG Enblad, C Sundström, S Gronowitz, et al.Medical Oncology (Northwood, London, England)|August 30, 2000
A more favourable clinical course of lymphoma relapsing after high-dose therapy: evidence of tumour heterogeneity?G Enblad, K Carlson, M Bengtsson, et al.Medical Oncology (Northwood, London, England)|June 21, 2005
Treatment of a patient with a nodal peripheral T-cell lymphoma (angioimmunoblastic T-Cell lymphoma) with a human monoclonal antibody against the CD4 antigen (HuMax-CD4)H Hagberg, M Pettersson, T Bjerner, et al.European Journal of Haematology|April 21, 1998
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective studyG Enblad, H Hagberg, A Gustavsson, et al.Pageof 4